Search result for 'alembic pharma'

Alembic Pharmaceuticals receives USFDA approval for its generic Diltiazem Hydrochloride extended-release capsules, indicated for hypertension treatment. The approval covers various strengths of the...

Alembic Pharmaceuticals receives USFDA approval for its generic Diltiazem Hydrochloride extended-release capsules used to treat hypertension, offering a cost-effective alternative to the brand-name...

Alembic Pharmaceuticals receives USFDA approval for its generic version of Paliperidone extended-release tablets, indicated for treating schizophrenia. The drug is therapeutically equivalent to...

Alembic Pharmaceuticals has received USFDA approval for its generic version of Albendazole Tablets, indicated for treating infections caused by worms like Taenia solium and Echinococcus granulosus.

Alembic Pharmaceuticals has received USFDA approval to market a generic medication for treating moderate-to-severe scalp psoriasis. The drug, Betamethasone Valerate Foam, is therapeutically...

Alembic Pharmaceuticals receives USFDA approval to market generic Nelarabine Injection for cancer treatment, expanding its portfolio to 211 ANDA approvals.

Alembic Pharmaceuticals receives tentative USFDA approval for its generic Selexipag injection, a treatment for pulmonary arterial hypertension. The company may be eligible for 180 days of generic...

Alembic Pharmaceuticals receives USFDA approval for its generic Bromfenac ophthalmic solution, indicated for post-cataract surgery inflammation and pain treatment.

Alembic Pharmaceuticals receives tentative USFDA approval for its generic Ivosidenib tablets, a treatment for certain types of cancer of bone marrow and bile duct. The drug is therapeutically...

Alembic Pharmaceuticals receives USFDA approval for generic Dabigatran Etexilate capsules 75 mg & 150 mg, used for stroke and blood clot prevention in adults with atrial fibrillation. The company...

Alembic Pharmaceuticals receives USFDA approval for its generic Icatibant injection, a treatment for acute attacks of hereditary angioedema (HAE) in adults. This is the company's first peptide...

Alembic Pharmaceuticals receives USFDA approval to market a generic medication for heart failure, a therapeutically equivalent version of Novartis's Entresto tablets.